VisionSense

Stereoscopic Sight for Minimally Invasive Surgery

Health Tech & Life Sciences
Acquired by Medtronic
Acquired Petah Tikva, Israel Founded 1998
Last updated 2026-06-18
Total raised
Last: 2004-09
Stage
Acquired
Founded
1998
Headcount
0
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Visionsense develops visualization solutions that bring natural stereoscopic sight to minimally invasive surgery. Using sensor technology and proprietary software, the Visionsense system delivers depth perception, 3D HD-resolution images, and maneuvering flexibility in the smallest access diameters. With stereovision capabilities, surgeons gain enhanced tissue understanding, improved hand-eye coordination, and the confidence to use advanced articulating surgical tools. The companys VSiii solution is based on a small-diameter (starting at 4 millimeters), single-channel endoscope that delivers visual information to a stereoscopic camera that imitates an insects compound eye. The VSiii system can be used in minimally invasive neurosurgery, ENT, arthroscopy (CE only), and general surgery procedures. It has been cleared by the FDA and CE and is used clinically on a regular basis worldwide.

Funding history · 1 round · — total

2004-09
Undisclosed

Q&A

What is VisionSense's primary focus?
VisionSense develops visualization solutions to provide natural stereoscopic sight for minimally invasive surgery.
When was VisionSense founded?
VisionSense was founded in July 1998.
What is the status of VisionSense?
VisionSense was acquired by Medtronic in April 2018 and is currently inactive.
What is VisionSense's core product?
VisionSense's VSiii solution is based on a small-diameter, single-channel endoscope that delivers visual information to a stereoscopic camera, providing depth perception and 3D HD-resolution images.
In which medical fields can the VSiii system be used?
The VSiii system can be used in minimally invasive neurosurgery, ENT, arthroscopy (CE only), and general surgery procedures.
Has VisionSense's product received regulatory clearances?
Yes, the VSiii system has been cleared by the FDA and CE.
Where is VisionSense headquartered?
VisionSense is headquartered in Petah Tikva, Israel.
Which investor participated in VisionSense's funding round in September 2004?
Peregrine Ventures participated in VisionSense's funding round in September 2004.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingPlatforms & InterfacesSoftwareSensing
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

medical-devicesimagingsurgical-instrumentsminimally-invasivelaparoscopyneurology3d-technologyoperating-roomsendoscopysurgerysensorssoftware-applicationsorthopedicsmedical-technologiesoptronics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

YouTubeyoutube.com/channel/UC2IhHDQq7fpLzC9lt7cYkwg

Identifiers & details

Founded1998-7
OfficesPhiladelphia
Status reasonAcquired (Inactive) by Medtronic on Apr 2018 - closed due to acquisition

Acquisitions & public offerings

Acquired by Medtronic 2018-04

Radar intelligence

Patents

EPO31